Manufacture

The potential of the cell and gene therapies sector depends – partially – on the expertise of the transport and logistics partners that complement it.

How can companies beat the bottlenecks in viral vector manufacturing?

Is renting material handling equipment the best way to help manufacturers tackle waste?

How Tosoh Biosciences is contributing to a fascinating project on a mission to develop a continuous production process using Escherichia Coli

US-based law and patenting experts offer their thoughts on IP protection in the digital age

Nominations are open now – but only until October 10.

What lies ahead for biopharma manufacturers when it comes to downstream analytical tech?

What sustainability benefits can be gained from smart choices and reduced material use?

While contamination issues continue to limit the potential of gene therapy, scientists can no longer afford to ignore the best detection methods.

I explore recent cases of pediatric cough medicines contaminated with diethylene glycol.